Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth …

Management outlined corrective actions and reaffirmed confidence in delivering 2025 EPS of at least $29.50. Biosimilar adoption remains a key growth driver, with plans to expand offerings in …

CouponFollow Extension

$29.50
OFF

Cigna Projects 2025 EPS Of At Least $29.50 Amid Biosimilar Growth …

2 weeks from now

Management outlined corrective actions and reaffirmed confidence in delivering 2025 EPS of at least $29.50. Biosimilar adoption remains a key growth driver, with plans to expand offerings in …

msn.com

27%
OFF

Cigna Projects 2025 EPS Of At Least $29.50 Amid Biosimilar Growth …

2 weeks from now

Jan 30, 2025 · CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, alongside adjusted EPS of $27.33, which fell short of expectations. He …

seekingalpha.com

19%
OFF

Cigna Sees FY25 Adjusted EPS $29.50 - Markets Insider

2 weeks from now

Jan 30, 2025 · Sees FY25 adjusted revenue at least $252,000. Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The Cigna (CI) Group’s …

businessinsider.com

27%
OFF

Cigna's 27% Revenue Increase In 2024 And The Outlook On 2025

2 weeks from now

Jan 30, 2025 · The Cigna Group reported today their total revenue of $247.1 billion for 2024, marking a significant 27% increase compared to $195.3 billion in 2023. This growth highlights …

managedhealthcareexecutive.com

$29.50
OFF

Cigna Group (CI) Earnings Outlook: Adjusted EPS And Revenue …

2 weeks from now

Jan 30, 2025 · Cigna expects its adjusted operating earnings per share (EPS) in 2025 to be at least $29.50, while estimates suggest $31.50. The Cigna Healthcare medical care ratio is …

smartkarma.com

$4
OFF

Cigna Group (CI) Q4 2024 Earnings Call Transcript

2 weeks from now

Jan 30, 2025 · For Cigna Healthcare, we expect full year 2025 adjusted earnings of at least $4.1 billion. This represents mid-single-digit year-over-year growth on a normalized basis.

fool.com

$29.50
OFF

The Cigna Group Reports Fourth Quarter And Full Year 2024 …

2 weeks from now

Jan 30, 2025 · The Cigna Group's outlook 2 for full year 2025 consolidated adjusted income from operations 1,2 is at least $29.50 per share 2. Additionally, this outlook includes the impact of …

prnewswire.com

$4
OFF

Cigna Group (CI) Q4 2024 Earnings Call Transcript - MSN

2 weeks from now

For Cigna Healthcare, we expect full year 2025 adjusted earnings of at least $4.1 billion. This represents mid-single-digit year-over-year growth on a normalized basis.

msn.com

10%
OFF

Positive Outlook For Cigna Driven By Strong EPS Growth And …

2 weeks from now

Nov 1, 2024 · The company also provided initial guidance for a 10% EPS growth in 2025, supported by favorable conditions such as the expansion of biosimilars and new client …

businessinsider.com

10%
OFF

Cigna Forecasts 2025 Profit Growth Of At Least 10% After Quarterly …

2 weeks from now

Oct 31, 2024 · (Reuters) -Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street expectations, driven by strong demand for its …

yahoo.com

27%
OFF

Evernorth Drives Cigna's Strong Revenue Growth And Focuses On ...

2 weeks from now

Jan 30, 2025 · Related: Cigna's 27% Revenue Increase in 2024 and the Outlook on 2025. In addition, specialty and care services recorded $90.3 billion in adjusted revenue, marking an …

managedhealthcareexecutive.com

10%
OFF

Cigna’s Strong Specialty Pharmacy Performance And Strategic …

2 weeks from now

Nov 1, 2024 · Looking towards 2025, Cigna has projected at least 10% growth in earnings per share, supported by several positive factors such as biosimilars, new client relationships, and …

businessinsider.com

8%
OFF

Cigna Reports $247B Revenue, Boosts Dividend 8% As Customer …

2 weeks from now

Jan 30, 2025 · The 2025 outlook of at least $29.50 EPS reflects management's confidence in addressing near-term challenges while maintaining growth momentum. The emphasis on …

stocktitan.net

$0
OFF

Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'

2 weeks from now

Sep 19, 2024 · For instance, on September 5 th, Cigna’s Evernorth Health Services announced plans to include a Stelara biosimilar for $0 out of pocket for eligible patients beginning in early …

seekingalpha.com

$29.50
OFF

Cigna To Tie Executive Compensation To Customer Satisfaction - MSN

2 weeks from now

The Cigna Group (CI) Q4 2024 Earnings Call Transcript; Cigna: Buy The Drop On This Undervalued Growth Stock; Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth …

msn.com

$375
OFF

Getting Biosimilars To Patients - Cigna Healthcare Newsroom

2 weeks from now

Aug 2, 2022 · Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower …

cigna.com

FAQs about Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth … Coupon?

How will Cigna HealthCare perform in 2025?

Management projects 2025 adjusted EPS of at least $29.50, supported by biosimilar growth and strategic investments. Full-year consolidated adjusted revenue is expected to exceed $252 billion. Cigna Healthcare earnings in 2025 are anticipated to reach at least $4.1 billion, with a medical care ratio ranging between 83.2%-84.2%. ...

How did Cigna perform in 2024?

Cigna delivered strong revenue growth in 2024 but faced challenges from elevated medical costs in its stop loss product. Management outlined corrective actions and reaffirmed confidence in delivering 2025 EPS of at least $29.50. Biosimilar adoption remains a key growth driver, with plans to expand offerings in 2025. ...

What is Cigna's outlook for fy25?

Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The Cigna (CI) Group’s outlook2 for full year 2025 consolidated adjusted income from operations1,2 is at least $29.50 per share. ...

How will Cigna's acquisitions affect its topline growth?

Assuming the company will allocate 1% of revenue towards M&A, acquisitions could contribute another 50bps to the overall topline growth. Over the past 3 years, Cigna has repurchased more than $17 billion of own shares, reducing their total shares outstanding significantly. ...

Is Cigna guiding for $235 billion in revenue & cash flow in fy24?

Cigna is guiding for at least $235 billion in revenue and $11 billion for cash flow from operations for FY24, as detailed in the table below. As the company has already delivered two strong quarters, I don’t expect any major surprises in the full-year results. I am thinking more about their normalized revenue growth from FY25 onwards. ...

Does Cigna HealthCare have a long-term earnings growth plan?

As shown in the chart below, Cigna is guiding for 6%-9% long-term earning growth, assuming 7%-10% growth from Cigna Healthcare. Cigna Healthcare offers a broad range of products and services including employer-sponsored medical plans, individual/family plans and other national healthcare benefit plans. ...